Artwork

Контент предоставлен BEaTS Research Radio. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией BEaTS Research Radio или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Player FM - приложение для подкастов
Работайте офлайн с приложением Player FM !

Sphingosine Kinase (SK) Inhibition: Ambushing the Ambush

14:14
 
Поделиться
 

Manage episode 454034737 series 2849626
Контент предоставлен BEaTS Research Radio. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией BEaTS Research Radio или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.

Omar Moghrabi from the University of Ottawa interviews Dr. Marceline Côté about using Sphingosine Kinase (SK) Inhibitors to treat enveloped viruses like Ebola. Dr. Côté is an associate professor at the University of Ottawa and the director of the Centre for Infection, Immunity, & Inflammation, where her research and practice involve antiviral treatments. In this episode, Dr. Côté weighs in on the emerging research that suggests that the use of SK inhibitors may be the future of broad-spectrum antiviral treatments. Omar and Dr. Côté discuss the mechanism, breadth, and safety of SK inhibitors in detail and the future of this post-entry approach to viral combat.
Learn more: https://www.uottawa.ca/faculty-medicine/dr-marceline-cote
0:03 | Introduction to the speaker
1:04 | Lay Summary/intro to the topic
1:54 | How do viruses like Ebola enter cells in the first place?
4:50 | What are sphingosine kinases, and why are they such a good target for blocking viruses?
6:00 | How effective is this approach across these viruses, and were there any surprises or interesting findings?
8:48 | The future of broad-spectrum antiviral treatments and the potential of SK inhibitors
10:22 | Known side effects of using SK inhibitors and safety concerns
11:54 | Impact of SK Inhibitor Therapies on Public Health Responses During Viral Outbreaks
13:16 | Outro and Thanks
Intro: Sunny Brazilian Bossa Nova Jazz Podcast - Denis-Pavlov-Music;
Outro: Context Sensitive - CHIPTUNE
https://www.youtube.com/ContextSensitive
https://contextsensitive.bandcamp.com/
Producer: Zaid Taweel
Editor: Zaid Taweel
Script Writers and Editors: Aws Almir Ahmad and Paul Al Haddad
Show Host: Omar Moghrabi

  continue reading

Разделы

1. Sphingosine Kinase (SK) Inhibition: Ambushing the Ambush (00:00:00)

2. Introduction to the speaker (00:00:03)

3. Lay Summary / intro to the topic (00:01:04)

4. How do viruses like Ebola enter cells in the first place? (00:01:54)

5. What are sphingosine kinases, and why are they such a good target for blocking viruses? (00:04:50)

6. How effective is this approach across these viruses and were there any surprises or interesting findings? (00:06:00)

7. The future of broad spectrum antiviral treatments and the potential of SK inhibitors (00:08:48)

8. Impact of SK inhibitor therapies on public health responses during viral outbreaks (00:11:54)

31 эпизодов

Artwork
iconПоделиться
 
Manage episode 454034737 series 2849626
Контент предоставлен BEaTS Research Radio. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией BEaTS Research Radio или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.

Omar Moghrabi from the University of Ottawa interviews Dr. Marceline Côté about using Sphingosine Kinase (SK) Inhibitors to treat enveloped viruses like Ebola. Dr. Côté is an associate professor at the University of Ottawa and the director of the Centre for Infection, Immunity, & Inflammation, where her research and practice involve antiviral treatments. In this episode, Dr. Côté weighs in on the emerging research that suggests that the use of SK inhibitors may be the future of broad-spectrum antiviral treatments. Omar and Dr. Côté discuss the mechanism, breadth, and safety of SK inhibitors in detail and the future of this post-entry approach to viral combat.
Learn more: https://www.uottawa.ca/faculty-medicine/dr-marceline-cote
0:03 | Introduction to the speaker
1:04 | Lay Summary/intro to the topic
1:54 | How do viruses like Ebola enter cells in the first place?
4:50 | What are sphingosine kinases, and why are they such a good target for blocking viruses?
6:00 | How effective is this approach across these viruses, and were there any surprises or interesting findings?
8:48 | The future of broad-spectrum antiviral treatments and the potential of SK inhibitors
10:22 | Known side effects of using SK inhibitors and safety concerns
11:54 | Impact of SK Inhibitor Therapies on Public Health Responses During Viral Outbreaks
13:16 | Outro and Thanks
Intro: Sunny Brazilian Bossa Nova Jazz Podcast - Denis-Pavlov-Music;
Outro: Context Sensitive - CHIPTUNE
https://www.youtube.com/ContextSensitive
https://contextsensitive.bandcamp.com/
Producer: Zaid Taweel
Editor: Zaid Taweel
Script Writers and Editors: Aws Almir Ahmad and Paul Al Haddad
Show Host: Omar Moghrabi

  continue reading

Разделы

1. Sphingosine Kinase (SK) Inhibition: Ambushing the Ambush (00:00:00)

2. Introduction to the speaker (00:00:03)

3. Lay Summary / intro to the topic (00:01:04)

4. How do viruses like Ebola enter cells in the first place? (00:01:54)

5. What are sphingosine kinases, and why are they such a good target for blocking viruses? (00:04:50)

6. How effective is this approach across these viruses and were there any surprises or interesting findings? (00:06:00)

7. The future of broad spectrum antiviral treatments and the potential of SK inhibitors (00:08:48)

8. Impact of SK inhibitor therapies on public health responses during viral outbreaks (00:11:54)

31 эпизодов

Все серии

×
 
Loading …

Добро пожаловать в Player FM!

Player FM сканирует Интернет в поисках высококачественных подкастов, чтобы вы могли наслаждаться ими прямо сейчас. Это лучшее приложение для подкастов, которое работает на Android, iPhone и веб-странице. Зарегистрируйтесь, чтобы синхронизировать подписки на разных устройствах.

 

Краткое руководство

Слушайте это шоу, пока исследуете
Прослушать